Electro-acupuncture (EA) and Chronic Pelvic Pain (CPP) (BMEA)

November 10, 2015 updated by: University of Edinburgh

The BMEA Study: The Impact of Meridian Balanced Method (BM) Electro-acupuncture (EA) Treatment on Women With Chronic Pelvic Pain (CPP): A Three-arm Randomized Controlled Pilot Study.

Chronic pelvic pain (CPP) is a debilitating condition that affects over 1 million women in the United Kingdom. The annual healthcare costs are estimated at over £150 million. Proven interventions which include the use of analgesics or hormonal treatments are unsatisfactory in many cases.

The investigators believe that the meridian balance method (BM) electro-acupuncture (EA) treatment (which includes a Traditional Chinese Medicine Health Consultation [TCM HC]) may be helpful in the management of CPP. Studies on the mechanisms of EA have demonstrated an analgesic effect. A recent individual patient data meta-analysis on the use of acupuncture for four chronic pain conditions found a small statistically significant effect size when compared to sham acupuncture. The effect size was larger and statistically significant when compared to usual care controls. This meta-analysis, and other large studies, suggests that, in addition to this analgesic effect, the interaction between the patient and the healthcare provider also plays a role in its effect on painful symptoms.

Our hypothesis is that the meridian BMEA treatment alleviates pain, and improves physical and emotional functioning, in women with CPP.

The investigators plan to undertake a single centre pilot study to assess the feasibility of performing a future three-armed randomised controlled, parallel group design trial to determine the efficacy of the meridian balance method electro-acupuncture (BMEA) treatment in the management of women with CPP.

The primary objective is to determine whether it is possible to achieve acceptable recruitment and retention rates within defined inclusion/exclusion criteria.

The secondary objectives are to determine the effectiveness and acceptability to patients of the proposed methods of recruitment, randomisation, interventions and assessment tools.

The investigators aim to recruit 30 women with CPP in NHS Lothian over a 12-month period and randomise them to BMEA treatment, TCM HC or standard care (SC). Response to the intervention will be monitored by validated pain, physical and emotional functioning questionnaires at weeks 0 (baseline), 4 (end of study) 8 and 12. Focus group discussion to gain feedback on study experience will be conducted at the completion of the study.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • City of Edinburgh
      • Edinburgh, City of Edinburgh, United Kingdom, EH16 4SA
        • Ooi Thye Chong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Chronic pelvic pain longer than 6 months duration
  • Average numerical pain score of at least 4 out of 10 in the previous week
  • Able and willing to comply with intervention
  • Women aged 18 and above

Exclusion Criteria:

  • Pregnancy
  • Malignancy
  • Severe bleeding disorders (e.g. Type 2, 3 Von Willebrand disease)
  • Severe needle phobia
  • Taking anti-coagulants
  • A history of seizure
  • A pace-maker in situ
  • Moderate to severe psychiatric illness (currently under the care of a psychiatrist)
  • Had received electro-acupuncture and meridian balanced method within the last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: EA treatment and TCM health consult
Participants randomized to the EA treatment will receive 2 EA +TCM health consult once a week x 4 weeks (8 total)
Electro acupuncture and traditional Chinese Medicine Health consult
Experimental: TCM health consult
Participants randomized to TCM health consult will receive 2 TCM health consult once a week x 4 weeks ( 8 total)
Traditional Chinese Medicine Health Consult without needling
Active Comparator: Usual care
Participants randomized to usual care will continue with their usual care
Standard NHS care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary objective is to determine whether it is possible to achieve acceptable recruitment and retention rates within defined inclusion/exclusion criteria.
Time Frame: At the end of study: 12 months from start of study
We aim to recruit 30 women with CPP in NHS Lothian over a 12-month period and randomise them to BMEA treatment, TCM HC or standard care (SC). Response to the intervention will be monitored by validated pain, physical and emotional functioning questionnaires at weeks 0 (baseline), 4 (end of study) 8 and 12. Focus group discussion to gain feedback on study experience will be conducted at the completion of the study.
At the end of study: 12 months from start of study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The secondary objectives are to determine the effectiveness and acceptability to patients of the proposed methods of recruitment, randomisation, interventions and assessment tools.
Time Frame: 12 months from date of recruitment
We aim to recruit 30 women with CPP in NHS Lothian over a 12-month period and randomise them to BMEA treatment, TCM HC or standard care (SC). Response to the intervention will be monitored by validated pain, physical and emotional functioning questionnaires at weeks 0 (baseline), 4 (end of study) 8 and 12. Focus group discussion to gain feedback on study experience will be conducted at the completion of the study.
12 months from date of recruitment
VAS Scale
Time Frame: At 0, 4, 8, 12 weeks
Questionnaire
At 0, 4, 8, 12 weeks
Brief Pain Inventory
Time Frame: At 0, 4, 8, 12 weeks
Questionnaire
At 0, 4, 8, 12 weeks
Hospital Anxiety and Depression Scale
Time Frame: at 0, 4, 8, 12 weeks
Questionnaire
at 0, 4, 8, 12 weeks
SF 12
Time Frame: at 0, 4, 8, 12 weeks
Questionnaire
at 0, 4, 8, 12 weeks
Work Productivity & Activity Impairment Questionnaire
Time Frame: at 0, 4, 8, 12 weeks
Questionnaire
at 0, 4, 8, 12 weeks
Sexual Activity Questionnaire
Time Frame: at 0, 4, 8, 12 weeks
Questionnaire
at 0, 4, 8, 12 weeks
Pain Catastrophising Questionnaire
Time Frame: at 0, 4, 8, 12 weeks
Questionnaire
at 0, 4, 8, 12 weeks
Focus Group Discussions
Time Frame: At the end of study
Qualitative Method
At the end of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Marie Fallon, MD PhD, University of University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

September 23, 2014

First Submitted That Met QC Criteria

November 14, 2014

First Posted (Estimate)

November 20, 2014

Study Record Updates

Last Update Posted (Estimate)

November 11, 2015

Last Update Submitted That Met QC Criteria

November 10, 2015

Last Verified

November 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on EA treatment

Subscribe